Literature DB >> 7543437

Enhanced nitric oxide synthase activity in portal hypertensive rabbits.

P A Cahill1, C Foster, E M Redmond, C Gingalewski, Y Wu, J V Sitzmann.   

Abstract

Portal hypertension (PHT) is characterized by splanchnic hyperemia caused by a reduction in mesenteric vascular resistance. Mediators of this hyperemia include nitric oxide (NO). This is based on several reports indicating a marked splanchnic hyporesponsiveness in PHT to vaso-constrictor stimuli, both in vitro and in vivo, and a subsequent reversal using specific inhibitors of NO synthase (NOS). The objective of this study was to determine directly if the generation of NO is altered in PHT vasculature. Thus, we compared NOS activity in the hyperemic vasculature of normal rabbits and rabbits with PHT (after undergoing partial portal vein ligation). Nicotinamide adenine dinucleotide phosphate diaphorase staining indicated the presence of NOS within the vascular endothelium. Ca(2+)-dependent NOS activity was significantly increased (P < .05) in PHT particulate fractions from the superior mesenteric artery and thoracic aorta, but not from the portal vein. There was no change in NOS activity within the cytosolic fractions. Arterial wall cyclic guanosine monophosphate (cGMP) levels and plasma nitrite levels were both significantly increased in PHT. These results show enhanced NOS activity in PHT hyperemic vessels concurrent with increased tissue cGMP levels. We conclude that enhanced NO synthesis contributes to the hyperdynamic circulation of PHT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543437

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

2.  Gastric mucosal resistance to acute injury in experimental portal hypertension.

Authors:  S Calatayud; M C Ramírez; M J Sanz; L Moreno; C Hernández; J Bosch; J M Piqué; J V Esplugues
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 3.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.

Authors:  A I Sarela; F M Mihaimeed; J J Batten; B R Davidson; R T Mathie
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Impaired adaptive cytoprotection to ethanol-induced damage in gastric mucosa of portal hypertensive rats.

Authors:  K Ninomiya; S Kitano; T Yoshida; T Bandoh; D Baatar; S Tsuboi
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

6.  Pulmonary expression of iNOS and HO-1 protein is upregulated in a rat model of prehepatic portal hypertension.

Authors:  R A Schroeder; C A Ewing; J V Sitzmann; P C Kuo
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

Review 7.  The portal hypertension syndrome: etiology, classification, relevance, and animal models.

Authors:  Jaime Bosch; Yasuko Iwakiri
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

8.  Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Authors:  Frédéric Moal; Nary Veal; Eric Vuillemin; Eric Barrière; Jianhua Wang; Lionel Fizanne; Frédéric Oberti; Olivier Douay; Yves Gallois; Dominique Bonnefont-Rousselot; Marie Christine Rousselet; Paul Calès
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat.

Authors:  A Kaviani; M Ohta; R Itani; F Sander; A S Tarnawski; I J Sarfeh
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

10.  The role of nitric oxide in systemic and hepatic haemodynamics in the rat in vivo.

Authors:  Xiangnong Li; Irving S Benjamin; Barry Alexander
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.